JDS-Cong govt is functioning as a commission agent: Yeddyurappa

Udupi, Jul 16: With two deaths in a single day, and receiving coronavirus positive report of a person who died two days ago, Udupi district’s covid-19 death toll today mounted to eight. 

A-49-year-old resident of Udupi, was admitted to Ajjarkad government hospital for other ailments. He was suffering from multiple health issues like diabetes and respiratory problems.

Last night he was tested positive for coronavirus and hence he was shifted to Dr TMA Pai COVID hospital in Udupi where he breathed his last today. 

A 54-year-old man from Maravanthe in Byndoor taluk, who was suffering from asthma, today died while being taken from one hospital to the other.

He was admitted to a private hospital in Kundapur on the evening of Wednesday. Today he was being shifted to Manipal hospital. However he breathed his last half way through.  

His body was taken back to Kundapur and throat swab of the deceased was sent for testing. As the sample of the deceased person was taken using rapid test kit, his report was available within half an hour and it showed positive for covid-19. 

Meanwhile, throat swabs of a man from Ankola in Uttar Kannada district, who passed away in Manipal Hospital on July 14, were tested positive today. His funeral was held at the Beedinagudde crematorium as per the COVID norms.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi, Jan 11: A case has been registered against Pune Billava president on the charges of issuing life threats to former Minister Vinay Kumar Sorake and Dinesh Amin Mattu at the Udupi Town Police station, police sources said on Saturday.

Former Minister Vinay Kumar Sorake along with like-minded Billawa organisations and the Udupi Muslim Federation jointly scheduled an inter-religious Billawa – Muslims Harmony meet on January 11, at the Town Hall.

Journalist Dinesh Amin Mattu was the speaker and Vinay Kumar Sorake was to preside over the programme.